escitalopram has been researched along with Anankastic Personality in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Ridder, M; Mograbi, D; Wolmarans, W | 1 |
| Botvinnik, A; Lerer, B; Lifschytz, T; Lotan, A; Saban, M; Salama, A; Shahar, O; Singh, S; Wolf, G; Yakobi, C | 1 |
| Chatard, A; Harika-Germaneau, G; Hashemian, F; Jaafari, N; Lafay-Chebassier, C; Langbour, N; Millet, B; Patri, S; Pérault-Pochat, MC; Solinas, M | 1 |
3 other study(ies) available for escitalopram and Anankastic Personality
| Article | Year |
|---|---|
Spontaneous alternation and stereotypical behaviour in deer mice: response to escitalopram and levetiracetam.
Topics: Animals; Escitalopram; Levetiracetam; Obsessive-Compulsive Disorder; Peromyscus; Stereotyped Behavior | 2022 |
Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Escitalopram; Hallucinogens; Male; Mice; Mice, Inbred ICR; Obsessive-Compulsive Disorder; Psilocybin; Receptor, Serotonin, 5-HT1A; Serotonin | 2023 |
Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive-compulsive disorder.
Topics: Brain-Derived Neurotrophic Factor; Escitalopram; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2022 |